Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 165

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 165
---
 customs authorities, report their forms either on themselves or via an entrusted agent to the customs and assume corresponding responsibilities. Cross-border e-commerce enterprises shall appoint a domestic enterprise registered in China to undergo customs registration procedures, assume the responsibility for factual reporting, accept supervision from relevant authorities in accordance with law, and assume joint civil liability.

According to the Announcement on Regulatory Matters
concerning Cross-Border E-commerce Retail Imports and Exports (《关于跨境电子商务零售进出口商品有关监管事宜的公告》)
promulgated by the General Administration of Customs on December 10, 2018 and implemented on January 1, 2019, cross-border e-commerce
platform enterprises, logistics enterprises, payment enterprises and other enterprises involved in cross-border e-commerce retail import
business shall, in accordance with the regulations on the administration of registration of customs declaration entities, undergo registration
procedures with the customs in the places where such enterprises are located. Overseas cross-border e-commerce enterprises shall appoint
domestic agents to undergo registration procedures with the customs in the places where the agents are located. Enterprises engaged in
cross-border e-commerce retail import and export business and registered with the customs shall be included in customs credit management,
with the customs authorities enforcing differentiated customs clearance management measures according to credit levels. Goods imported
through “Imports via Direct Purchase” (直购进口) in cross-border e-commerce and those applicable
to the import policy of “Bonded Imports via Online Shopping” (网购保税进口) are subject
to the regulation as inbound items for personal use but not subject to the requirements for initial import approval, registration and
recordation of relevant goods.

Advertising of Healthcare Food and Pharmaceuticals

With reference to the Advertising Law of the
PRC (《中华人民共和国广告法》) promulgated by SCNPC on October
27, 1994 and last amended on April 29, 2021, advertisements for pharmaceuticals, medical equipment and healthcare food shall be reviewed
by relevant authorities before their release and are prohibited from release without review. Health food advertisements should prominently
state that “this product cannot replace drugs. “Moreover, according to the Advertising Law of the PRC, advertisements shall
not contain any false or misleading content and shall not deceive or mislead consumers, and except for advertisements for medical treatment,
pharmaceuticals or medical devices, any other advertisement is prohibited from involvement in disease treatment